Developed by the PHA Scientific Leadership Council, this program offers, at nationally recognized PAH centers, direct instruction on state-of-the-art PAH diagnosis and management for physicians and other health professionals who help care for patients with PAH.
These day-long highly interactive preceptorships build links among community PAH specialists, non-specialists, and clinicians at established PAH centers, creating new avenues for communication and more comprehensive, state-of-the-art diagnosis, initial treatment, and long-term management of patients with PAH.
- All programs are scheduled from 9:00 a.m. – 3:30 p.m.
- A complimentary breakfast and lunch are provided
- This program is FREE
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PAH.
The PHA Preceptorship Program is designed to improve competence, performance, and patient care practices by instructing front-line clinicians in the highest quality of care for patients with PAH by combining didactic discourse and highly interactive case-based discussion. At the conclusion of this program, participants should be able to:
- Define key pathophysiologic and epidemiologic components of PAH
- Accurately diagnose patients through comprehensive screening and early recognition of symptoms
- Evaluate the patient’s condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
- Tailor comprehensive care for complex patient populations
Accreditation and Credit Designation
This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians.
Washington University designates this live activity for a maximum of 5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of off-label/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.
|Sept. 30, 2016||Washington, D.C.|
|Oct. 21, 2016||Ann Arbor, Mich.|
|Oct. 28, 2016||Pittsburgh, Pa.|
|Nov. 4, 2016||New York, N.Y.|
|Nov. 4, 2016||San Diego (La Jolla), Calif.|
|Nov. 11, 2016||Orlando (Celebration), Fla.|
|Nov. 11, 2016||Milwaukee (Wauwatosa), Wis.|
|Dec. 2, 2016||Birmingham, Ala.|
|Dec. 9, 2016||Houston, Texas (For Pediatricians)|
|Dec. 9, 2016||Philadelphia, Pa.|
For more information, or to be informed when the locations are announced, please email Medical@PHAssociation.org.
|Actelion Pharmaceuticals US, Inc.||Gilead Sciences, Inc.||United Therapeutics Corporation|